Key result
Cardiotoxicity research expands rapidly, with immune checkpoint inhibitor myocarditis emerging as the primary hotspot.
Why the study?
With growing emphasis on cardiotoxicity research over the past 12 years, this study aimed to explore emerging trends and the evolution of research hotspots in the field.
This bibliometric analysis maps the rapid expansion of cardiotoxicity research over 12 years, highlighting cardio-oncology, immune checkpoint inhibitors, and myocarditis as key emerging hotspots.
Background: There is growing emphasis on the cardiotoxicity research over the past 12 years. To look for the hotspots evolution and to explore the emerging trends in the field of cardiotoxicity, publications related to cardiotoxicity were acquired from the Web of Science Core Collection on August 2, 2022. Methods: We used the CiteSpace 5.8 R3 and VOSviewer 1.6.18 to perform bibliometric and knowledge-map analysis. Results: A total of 8,074 studies by 39,071 authors from 6,530 institutions in 124 countries or regions were published in different academic journals. The most productive country was absolutely the United States, and the University of Texas MD Anderson Cancer Center was the institution with the largest output. Zhang, Yun published the most articles, and the author who had the most frequent co-citations was Moslehi, Javid. New England Journal of Medicine was the most frequently cited journals in this field. Mechanisms of cardiotoxicity have received the most attention and was the main research directions in the field. The disease of cardiotoxicity together with the related risk factors are potential research hotspots. Immune checkpoint inhibitor and myocarditis are two recently discussed and rapidly expanding research topic in the areas of cardiotoxicity. Conclusions: This bibliometric analysis provided a thorough analysis of the cardiotoxicity, which would provide crucial sources of information and concepts for academics studying this area. As a rapidly expanding field in cardiology, the related field of cardiotoxicity will continue to be a focus of research.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2023) studied Cardiotoxicity (n=8,074). Bibliometric analysis was evaluated on Publication trends, hotspots evolution, and knowledge structure. Between 2010 and 2022, cardiotoxicity research grew rapidly, with the United States as the leading contributor and immune checkpoint inhibitors and myocarditis emerging as recent research hotspots.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: